This is the authors' abstract. We don't add key points for this paper.
The herpesvirus saimiri genome encodes a complement control protein homolog (CCPH). Stable mammalian cell transfectants expressing a recombinant transmembrane form of CCPH (mCCPH) or a 5'FLAG epitope-tagged mCCPH (5'FLAGmCCPH) conferred resistance to complement-mediated cell damage by inhibiting the lytic activity of human serum complement. The function of CCPH was further defined by showing that the mCCPH and the 5'FLAGmCCPH transfectants inhibited C3 convertase activity and effectively reduced cell surface deposition of the activated complement component, C3d.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Fodor et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: